top
Search terms
Results 1 - 8 of 8 - ordered by :
Ehjournal

Abstract Aims The reninangiotensin system plays a central role in patients with established cardiovascular (CV) disease, but the prognostic effect of plasma renin in the community is ...

European Heart Journal, de Boer, Rudolf A., Schroten, Nicolas F., Bakker, Stephan J.L., Mahmud, Hasan, Szymanski, Mariusz K., van der Harst, Pim, Gansevoort, Ron T., van Veldhuisen, Dirk J., van ...

Date : 01/09/2012 Item size : 271703 bytes
Ehjournal

Abstract Aims An increased pulse pressure (PP) has consistently predicted increased cardiovascular morbidity and mortality in cardiovascular risk patients and mild chronic heart failure ...

European Heart Journal, Voors, Adriaan A., Petrie, Colin J., Petrie, Mark C., Charlesworth, Andrew, Hillege, Hans L., Zijlstra, Felix, McMurray, John J., van Veldhuisen, Dirk J.

Date : 01/09/2005 Item size : 172421 bytes
Ehjournal

Methods and results In 8592 subjects of the Prevention of Renal and Vascular End-stage Disease (PREVEND), a community-based, middle-aged cohort study, we performed cause-specific hazard analyses to ...

European Heart Journal, Brouwers, Frank P., de Boer, Rudolf A., van der Harst, Pim, Voors, Adriaan A., Gansevoort, Ron T., Bakker, Stephan J., Hillege, Hans L., van Veldhuisen, Dirk J., van Gilst, ...

Date : 14/05/2013 Item size : 289303 bytes
Ehjournal

See page 2577 for the editorial comment on this article (doi:10.1093/eurheartj/ehq307) Introduction Erythropoietin (EPO) is commonly known as an effective treatment for anaemia, partly caused by an ...

European Heart Journal, Voors, Adriaan A., Belonje, Anne M.S., Zijlstra, Felix, Hillege, Hans L., Anker, Stefan D., Slart, Riemer H.J.A., Tio, René A., van ‘t Hof, Arnoud, Jukema, J. Wouter, ...

Date : 01/11/2010 Item size : 280692 bytes
Ehjournal

Abstract Aims The reninangiotensin system plays a central role in patients with established cardiovascular (CV) disease, but the prognostic effect of plasma renin in the community is ...

European Heart Journal, de Boer, Rudolf A., Schroten, Nicolas F., Bakker, Stephan J.L., Mahmud, Hasan, Szymanski, Mariusz K., van der Harst, Pim, Gansevoort, Ron T., van Veldhuisen, Dirk J., van ...

Date : 01/09/2012
Ehjournal

Methods and results In 8592 subjects of the Prevention of Renal and Vascular End-stage Disease (PREVEND), a community-based, middle-aged cohort study, we performed cause-specific hazard analyses to ...

European Heart Journal, Brouwers, Frank P., de Boer, Rudolf A., van der Harst, Pim, Voors, Adriaan A., Gansevoort, Ron T., Bakker, Stephan J., Hillege, Hans L., van Veldhuisen, Dirk J., van Gilst, ...

Date : 14/05/2013
Ehjournal

See page 2577 for the editorial comment on this article (doi:10.1093/eurheartj/ehq307) Introduction Erythropoietin (EPO) is commonly known as an effective treatment for anaemia, partly caused by an ...

European Heart Journal, Voors, Adriaan A., Belonje, Anne M.S., Zijlstra, Felix, Hillege, Hans L., Anker, Stefan D., Slart, Riemer H.J.A., Tio, René A., van ‘t Hof, Arnoud, Jukema, J. Wouter, ...

Date : 01/11/2010
Ejhf

Optimizing clinical use of biomarkers in high‐risk acute heart failure patients [6, 7] Cleland et al., in a post-hoc analysis of data from the Placebo-controlled Randomized Study of the Selective ...

European Journal of Heart Failure, Demissei, Biniyam G., Valente, Mattia A.E., Cleland, John G., O'Connor, Christopher M., Metra, Marco, Ponikowski, Piotr, Teerlink, John R., Cotter, Gad, Davison, ...

Date : 01/03/2016 Item size : 225124 bytes